BONE DISEASE ASSOCIATED WITH TOTAL PARENTERAL NUTRITION

[1]  J. Harrison,et al.  Metabolic bone disease in patients receiving long-term total parenteral nutrition. , 1980, Annals of internal medicine.

[2]  R. DeFronzo,et al.  The effects of glucose and insulin on renal electrolyte transport. , 1976, The Journal of clinical investigation.

[3]  M. Haussler,et al.  Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. , 1976, The Journal of clinical investigation.

[4]  J. Wergedal,et al.  Quantitative histological studies on the pathogenesis of uremic bone disease. , 1974, The Journal of clinical endocrinology and metabolism.

[5]  D. Calloway,et al.  Studies in calcium metabolism. I. The calciuretic effect of dietary protein. , 1974, The American journal of clinical nutrition.

[6]  H. DeLuca,et al.  Strontium Induced Rickets: Metabolic Basis , 1971, Science.

[7]  J. Lemann,et al.  Evidence that glucose ingestion inhibits net renal tubular reabsorption of calcium and magnesium in man. , 1970, The Journal of laboratory and clinical medicine.

[8]  E M Carlisle,et al.  Silicon: A Possible Factor in Bone Calcification , 1970, Science.

[9]  R. Holman,et al.  The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. , 1960, The Journal of nutrition.

[10]  A. Norman,et al.  [56] Steroid competition assay for determination of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D , 1980 .

[11]  C. Dent,et al.  Vitamin D, Rickets, and Osteomalacia , 1977 .

[12]  J. Jowsey,et al.  Long-term effects of high phosphate intake on parathyroid hormone levels and bone metabolism. , 1974, Acta orthopaedica Scandinavica.

[13]  B. Morgan Osteomalacia, renal osteodystrophy, and osteoporosis , 1973 .